Sam's News — health — 2026-09-15¶
Science¶
7.5 Ancient DNA reveals plague killed Siberian hunter-gatherers 5,500 years before Black Death¶
Ancient DNA analysis reveals Yersinia pestis killed Siberian hunter-gatherers approximately 5,500 years ago, predating the Black Death by millennia. DNA from the plague bacterium was detected in 18 of 46 individuals tested (40 percent), with an unusually high concentration of child and adolescent deaths suggesting severe lethality despite lacking later transmission-enabling mutations.
- Plague detected in prehistoric Lake Baikal remains ~5,500 years ago
- 40 percent detection rate in 46 individuals tested
- Concentrated deaths among children and young teenagers
- Published in Nature, led by Ruairidh Macleod (Oxford)
- Early strains may have carried severe immune-reaction genetic factors
Sources: ScienceDaily AI Web Searched, ScienceDaily — Health RSS
Health¶
7.5 Scientists Identify Major Epigenetic Brain Changes Between Ages 50 and 75¶
Researchers identified major epigenetic and structural brain changes occurring between ages 50 and 75, including sharp decline in embryonically-derived microglia, reduced blood-brain barrier maintenance, and erosion of three-dimensional genome architecture. The findings, published in Science using single-cell methods on hippocampal tissue, suggest these changes may explain why aging is the strongest risk factor for Alzheimer's disease and neurodegeneration.
- Age window: ages 50–75 shows sharp decline in embryonically-derived microglia
- Microglia replaced by cells with pro-inflammatory molecular signatures
- Substantial decline in blood-brain barrier maintenance populations
- Broad erosion of 3D genome architecture across multiple brain cell types
- Aging is strongest risk factor for Alzheimer's disease
Sources: ScienceDaily AI Web Searched, ScienceDaily — Health RSS
7.5 Fourth Measles Death Reported in Pennsylvania Within One Month¶
Pennsylvania reported a fourth measles-related death on September 15, 2026—an unvaccinated 18-year-old who died of acute disseminated encephalomyelitis (ADEM). The deaths, all among unvaccinated individuals, occurred within one month; Pennsylvania's 2026 outbreak has grown to nearly 700 cases across 38 counties, marking the state's first measles deaths in 35 years and contributing to the worst U.S. year for measles since 1991.
- Fourth measles death in Pennsylvania in one month (all unvaccinated)
- Sept 15 victim: 18-year-old from Mifflin County; cause ADEM (rare neurological complication)
- Pennsylvania 2026 outbreak: ~700 illnesses across 38 counties; ~100 cases in prior 7 days
- First measles deaths in Pennsylvania in 35 years
- U.S. 2026: worst year for measles since 1991; 7 deaths in last two years
Sources: STAT News AI Web Searched
7.5 New World Screwworm Parasite Returns to United States After Eradication¶
The New World screwworm—a flesh-eating parasite eradicated from the U.S. in the 1950s—has returned with confirmed detections in Texas and New Mexico. The parasite poses risks to livestock, wildlife, pets, and rarely humans; researchers developed a tracking dashboard to predict spread using environmental data and news reports, aiming to provide early detection before traditional public health reporting systems.
- Parasite eradicated from U.S. in 1950s; returns with detections in Texas and New Mexico
- 1950s damage estimate: $50–$100 million annually in U.S. livestock losses
- New World screwworm feeds on healthy, living flesh (unlike most fly larvae)
- Researchers developed tracking dashboard to predict spread and identify county-level risk
- Females lay eggs in open wounds or natural body openings
Sources: UC San Diego via ScienceDaily AI Web Searched, ScienceDaily — Health RSS
7 Vera's Trutakna kidney drug shows strong Phase 3 results in IgAN treatment¶
Vera Therapeutics announced positive final two-year Phase 3 results for Trutakna, demonstrating kidney function stabilization and reduced mortality risk in IgA nephropathy patients. The drug received accelerated FDA approval in July 2026; the company will seek full approval in Q4 2026.
- Stabilized kidney function in IgAN patients
- Reduced kidney-related death and complication risk
- Accelerated FDA approval received July 2026
- Full approval sought Q4 2026
- Addresses IgA nephropathy, chronic autoimmune kidney disease
Sources: STAT AI Web Searched, STAT News RSS
7 Meta-Analysis of 139 Trials Finds Knee Braces Most Effective for Osteoarthritis Pain¶
A network meta-analysis of 139 clinical trials involving nearly 10,000 patients found knee braces most effective for knee osteoarthritis pain relief, stiffness reduction, and physical function improvement. Water-based therapy proved especially effective for pain; regular exercise provided consistent benefits. Ultrasound ranked near the bottom, while high-intensity laser and shock wave therapies showed promise in specific areas.
- Meta-analysis: 139 trials, ~10,000 patients, 12 non-drug KOA treatments
- Knee braces ranked highest for pain, stiffness, and physical function
- Water-based therapy (hydrotherapy): especially effective for pain reduction
- Regular exercise: consistent benefits for pain and physical function
- Ultrasound: consistently ranked near bottom; limitations noted in trial design variation
Sources: ScienceDaily AI Web Searched, ScienceDaily — Health RSS
6.5 Cell 'Antenna' Mutations May Explain Congenital Heart Defects¶
Researchers identified a cellular communication system in microscopic 'antennae' (cilia) whose disruption may explain how genetic mutations cause congenital heart defects and affect other organs.
Sources: ScienceDaily RSS, ScienceDaily — Health RSS
6.5 Obesity drug manufacturers begin testing in children as young as 6¶
Pharmaceutical companies are conducting clinical trials of obesity medications in children as young as age 6.
Sources: STAT News RSS
Health & AI¶
7 Medicare AI prior authorization pilot plagued by rushed rollout and operational failures¶
Internal documents reveal Medicare's AI prior authorization pilot (WISeR model) launched hastily in January 2026 across six states despite significant operational problems and delayed patient care. The program, operating in New Jersey, Ohio, Oklahoma, Texas, Arizona, and Washington, is scheduled to run until 2031 and requires pre-approval for certain procedures including skin substitutes and epidural injections.
- WISeR model launched January 2026 across six states
- Hastily rolled out with initial operational failures
- Vendor warned CMS realistic timeline was unmet
- Delayed patient care documented in internal records
- Scheduled to run until 2031
Sources: STAT News AI Web Searched
Immigration Policy¶
6.5 Federal Judge Blocks Trump Administration Visa Length Restrictions for Graduate Students and Postdocs¶
A federal court halted the president of the United States administration's attempt to cap F-1 and J-1 visas for academic researchers at four years.
Sources: STAT News RSS